Pleomorphic Lobular Carcinoma in Situ (PLCIS) on breast core needle biopsies: Clinical significance and immunoprofile

American Journal of Surgical Pathology

Volumn 32, Issue 11, 2008, Pages 1721-1726

  Chivukula, Mamatha ^a   Haynik, Denise M ^a   Brufsky, Adam ^b   Carter, Gloria ^a   Dabbs, David J ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

DCIS; E cadherin; Lobular carcinoma in situ; P120 catenin; Pleomorphic

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P120; UVOMORULIN; TUMOR MARKER;

ARTICLE; BREAST BIOPSY; CARCINOMA IN SITU; CELL MEMBRANE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EOSINOPHIL COUNT; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; NEEDLE BIOPSY; PLEOMORPHIC LOBULAR CARCINOMA; AGED; BREAST TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA, LOBULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 56149097211     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31817dc3a6     Document Type: Article

References (19)

1. Bentz JS, Yassa N, Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol. 1998;11:814-822.
2. Dabbs DJ, Bhargava R, Chivukula M. The utility of p120 catenin in the diagnosis of lobular carcinoma of the breast. Am J Surg Pathol. 2007;31:427-437.
3. Dabbs DJ, Kapali M, Chivukula M, et al. The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of breast. Appl Immunohistochem Mol Morphol. 2007;15:260-266.
4. Downs-Kelly E, Bell D, Sneige N, et al. Management of pleomorphic lobular carcinoma in situ (supplement 1): Abstract no. 119:29A. Modern Pathology 2008; 97th Annual Meeting of United States and Canadian Academy of Pathology, March 1-7, Denver, CO.
5. Dixon JM, Anderson TJ, Page DL, et al. Infiltrating lobular carcinoma of the breast. Histopathology. 1982;6:149-161.
6. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ. A Correlative Study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29:534-543.
7. Eusebi V, Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol. 1992;23:655-662.
8. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia (lobular carcinoma in situ) with comedotype necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol. 2006;30:1445-1453.
9. Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Case review. Path Case Rev. 1996;1:27-30.
10. Haynik D, Chivukula M, Brufsky A, et al. Biophenotype of pleomorphic lobular carcinoma in situ on core needle biopsies carcinoma. Modern Pathology 2008 (supplement 1): Abstract no.157:37A. 97th Annual Meeting of United States and Canadian Academy of Pathology, March 1-7, Denver, CO.
11. Haynik D, Chivukula M, Brufsky A, et al. Clinical significance of pleomorphic lobular carcinoma in situ (PLCIS) on core needle biopsies with surgical excisional follow-up. Modern Pathology 2008 (supplement 1): Abstract no. 158:37A. 97th Annual Meeting of United States and Canadian Academy of Pathology, March 1-7, Denver, CO.
12. Jacobs TW, Pliss N, Kouria G, et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol. 2001;25:229.
13. Karabakhtsian RG, Johnson R, Sumkin J, et al. The clinical significance of lobular neoplasia on breast core biopsy. Am J Surg Pathol. 2007;31:717-723.
14. Lieberman L, Dershaw DD, Dalbs D, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings. Am J Roentgenol. 1999;173:291.
15. Middleton LP, Palacios DM, Bryant BR, et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol. 2000;24:1650-1656.
16. Rosen PP. Breast Pathology. Lobular Carcinoma In Situ. 2nd ed. Philadelphia: Lippincott Williams & Wilkins Press; 2002:581-626.
17. Sneige N, Wang J, Baker BA, et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol. 2002;15: 1044-1050.
18. Sapino A, Frigerio A, Peterse JL, et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch. 2000;436: 421-430.
19. Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol. 1992;23:1167-1171.